Axpharm Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Axpharm Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers

Secondary Activities: All Other Food Manufacturing | Other Basic Inorganic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | Other Plastics Product Manufacturing | Medical Equipment and Supplies Manufacturing | Electronic Shopping and Mail-Order Houses | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full name: Axpharm Sp. z o.o.

Profile Updated: April 12, 2024

Axpharm Sp. z o.o is a medical company specializing in the creation and manufacturing of ear, nose, and throat medical products, with a focus on laryngology. Their products, including nasal sprays, throat sprays, ear sprays, and drops, are designed and manufactured to the highest standards for medical devices in accordance with ISO:13485. They have developed patented medical products such as Otovent, a set for the balance of pressure in the middle ear.

Headquarters
Ul. Hermana Frankego 5A
Bydgoszcz; Kujawsko-Pomorskie; Postal Code: 85-862

Contact Details: Purchase the Axpharm Sp. z o.o. report to view the information.

Website: http://www.axpharm.eu/

Basic Information

Total Employees:

Purchase the Axpharm Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Axpharm Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Axpharm Sp. z o.o. report to view the information.

Incorporation Date:

June 27, 2008

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

88%

Company Performance

Financial values in the chart are available after Axpharm Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

51.08%▲

Total operating revenue

51.35%▲

Operating profit (EBIT)

84.17%▲

EBITDA

63.37%▲

Net Profit (Loss) for the Period

84.14%▲

Total assets

-1.33%▼

Total equity

144.72%▲

Operating Profit Margin (ROS)

3.68%▲

Net Profit Margin

3.34%▲

Return on Equity (ROE)

-19.45%▼

Similar companies